Predicting treatment outcome using kinome activity profiling in HER2+ breast cancer biopsies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predicting treatment outcome using kinome activity profiling in HER2+ breast cancer biopsies

Published:2024-06 Issue:6 Volume:27 Page:109858
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Debets Donna O.,de Graaf Erik L.,Liefaard Marte C.,Sonke Gabe S.,Lips Esther H.,Ressa Anna,Altelaar Maarten^ORCID

Funder

Horizon 2020

NWO

Publisher

Elsevier BV

Reference42 articles.

1. The molecular portraits of breast tumors are conserved across microarray platforms;Hu;BMC Genom.,2006

2. Breast cancer;Harbeck;Nat. Rev. Dis. Primers,2019

3. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer;Andrulis;J. Clin. Oncol.,1998

4. HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues;Owens;Clin. Breast Cancer,2004

5. Humanization of an anti-p185HER2 antibody for human cancer therapy;Carter;Proc. Natl. Acad. Sci. USA,1992

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP